ConductScience.org, home

Paper36077458

PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.

Kálmán-Szabó I and 11 others. Int J Mol Sci, 2022. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA. Papers, record 36077458. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36077458

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
PET Probes for Preclinical Imaging of GRPR-Positive Prostate Cancer: Comparative Preclinical Study of [68Ga]Ga-NODAGA-AMBA and [44Sc]Sc-NODAGA-AMBA.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.62
iCite
Revised in PubMed
2025-07-28
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kálmán-Szabó IIbolya
2Szabó JPJudit P
3Arató VViktória
4Dénes NNoémi
5Opposits GGábor
6Jószai IIstván
7Kertész IIstvánhttps://orcid.org/0000-0002-3822-9068
8Képes ZZita
9Fekete AAnikóhttps://orcid.org/0000-0002-0951-6092
10Szikra DDezső
11Hajdu IIstvánhttps://orcid.org/0000-0001-8008-7756
12Trencsényi GGyörgyhttps://orcid.org/0000-0001-6456-6212

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Prostatic NeoplasmsMajor topic
Receptors, BombesinMajor topic
Acetates
Animals
Bombesin
Cell Line, Tumor
Gallium Radioisotopes
Heterocyclic Compounds, 1-Ring
Humans
Male
Mice
Positron-Emission Tomography

Source PubMed

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132,946,975In vivo assessment of aminopeptidase N (APN/CD13) specificity of different 68Ga-labelled NGR derivatives using PET/MRI imaging.Int J Pharm2020https://conductscience.org/library/papers/32946975PubMed
227,497,631Co-administration of succinylated gelatine with a (99m)Tc-bombesin analogue, effects on pharmacokinetics and tumor uptake.Nucl Med Biol2016https://conductscience.org/library/papers/27497631PubMed
319,398,012Peptide receptor imaging of prostate cancer with radiolabelled bombesin analogues.Methods2009https://conductscience.org/library/papers/19398012PubMed
418,383,55868Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals.Contrast Media Mol Imaging2008https://conductscience.org/library/papers/18383558PubMed
526,774,390Imaging quality of (44)Sc in comparison with five other PET radionuclides using Derenzo phantoms and preclinical PET.Appl Radiat Isot2016https://conductscience.org/library/papers/26774390PubMed
625,389,697Matching the decay half-life with the biological half-life: ImmunoPET imaging with (44)Sc-labeled cetuximab Fab fragment.Bioconjug Chem2014https://conductscience.org/library/papers/25389697PubMed
78,022,709
Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
Prostate1994https://conductscience.org/library/papers/8022709PubMed
828,102,50744Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617-preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617.EJNMMI Res2017https://conductscience.org/library/papers/28102507PubMed
935,745,585Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35745585PubMed
1019,115,523Regulation and signaling of human bombesin receptors and their biological effects.Curr Opin Endocrinol Diabetes Obes2009https://conductscience.org/library/papers/19115523PubMed
1128,097,756AAZTA: An Ideal Chelating Agent for the Development of 44 Sc PET Imaging Agents.Angew Chem Int Ed Engl2017https://conductscience.org/library/papers/28097756PubMed
1222,682,112Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET.EJNMMI Res2012https://conductscience.org/library/papers/22682112PubMed
132,390,263Bombesin increases fetal lung growth and maturation in utero and in organ culture.Am J Respir Cell Mol Biol1990https://conductscience.org/library/papers/2390263PubMed
1423,649,462Functional and molecular imaging of localized and recurrent prostate cancer.Eur J Nucl Med Mol Imaging2013https://conductscience.org/library/papers/23649462PubMed
152,539,244Bombesin stimulates growth of human prostatic cancer cells in vitro.Cancer1989https://conductscience.org/library/papers/2539244PubMed
1629,564,38544Sc for labeling of DOTA- and NODAGA-functionalized peptides: preclinical in vitro and in vivo investigations.EJNMMI Radiopharm Chem2017https://conductscience.org/library/papers/29564385PubMed
1720,182,713A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues.Eur J Nucl Med Mol Imaging2010https://conductscience.org/library/papers/20182713PubMed
1821,680,701PET of somatostatin receptor-positive tumors using 64Cu- and 68Ga-somatostatin antagonists: the chelate makes the difference.J Nucl Med2011https://conductscience.org/library/papers/21680701PubMed
197,902,829Effect of somatostatin analog RC-160 and bombesin/gastrin releasing peptide antagonist RC-3095 on growth of PC-3 human prostate-cancer xenografts in nude mice.Int J Cancer1993https://conductscience.org/library/papers/7902829PubMed
2026,561,028In Vivo Evaluation of a Bombesin Analogue Labeled with Ga-68 and Co-55/57.Mol Imaging Biol2016https://conductscience.org/library/papers/26561028PubMed

See all 47 references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42,339,117The gastrin-releasing peptide receptor in oncology: a comprehensive review of recent advances in targeted radionuclide theranostics.Front Oncol2026https://conductscience.org/library/papers/42339117PubMed
41,425,801Functional D- and L‑Naphthalenediimide-Peptides: Microwave-Driven Synthesis, Supramolecular Aggregation, and Multiphoton Fluorescence Lifetime Imaging Microscopy in Living Cells.ACS Bio Med Chem Au2025https://conductscience.org/library/papers/41425801PubMed
41,217,470A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer.Eur J Nucl Med Mol Imaging2026https://conductscience.org/library/papers/41217470PubMed
39,474,267Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine.Chem Biomed Imaging2024https://conductscience.org/library/papers/39474267PubMed
38,020,178GRPR-targeting radiotheranostics for breast cancer management.Front Med (Lausanne)2023https://conductscience.org/library/papers/38020178PubMed
37,108,559Scandium-44: Diagnostic Feasibility in Tumor-Related Angiogenesis.Int J Mol Sci2023https://conductscience.org/library/papers/37108559PubMed

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GRP2,922PubTator's text mininghttps://conductscience.org/library/genes/2922NCBI Gene
GRPR2,925PubTator's text mininghttps://conductscience.org/library/genes/2925NCBI Gene

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36077458

GET https://conductscience.org/api/papers/v1/36077458/references?page=2